Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · September 05, 2017

Long-Term Safety of Crisaborole Ointment 2% for Mild to Moderate Atopic Dermatitis

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Long-Term Safety of Crisaborole Ointment 2% in Children and Adults With Mild to Moderate Atopic Dermatitis
J Am Acad Dermatol 2017 Aug 17;[EPub Ahead of Print], LF Eichenfield, RS Call, DW Forsha, J Fowler, AA Hebert, M Spellman, LF Stein Gold, M Van Syoc, LT Zane, E Tschen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading